RGA medical directors provide expert insights during pandemic

  • Dr. Dan Zimmerman

    Dr. Dan Zimmerman

    Senior Vice President, Head of Global Medical

  • Dr. Dave Rengachary

    Dr. Dave Rengachary

    Senior Vice President, Chief Medical Director, U.S. Mortality Markets

RGA’s medical team rose to the many challenges of 2020, equipping clients with a deeper understanding of the latest mortality, morbidity, and healthcare developments and trends and helping deliver consumer-focused insurance solutions across all regions.

The ongoing COVID-19 pandemic has impacted everyone’s role in the insurance industry, and that certainly includes medical directors, who have been tasked with providing medical and epidemiological expertise since the beginning to help inform business decisions.

RGA medical doctors around the world played an instrumental role in helping RGA, our clients, and the industry respond to the COVID-19 pandemic in 2020. The range of specialties among RGA doctors in the Global Medical, U.S. Mortality Markets, and regional and local teams gave clients early access to expert advice and insights into how the disease could affect all aspects of insurance.

Those medical insights also helped inform RGA’s underwriting and claims guidance, policy decisions, and business continuity measures worldwide.

Knowledge sharing included more than 200 webinars, research papers, and articles, as well as individual client outreach. RGA doctors introduced a new content format alongside our traditional thought leadership communications: COVID-19 Briefs, shorter pieces that allowed for flexibility and quick responses to the rapidly changing developments around the pandemic. Topics covered everything from potential treatment options and vaccine development to risk assessment considerations for people with certain chronic diseases.

The RGA medical team also manages the Longer Life Foundation (LLF) which is focused on researching drivers affecting mortality and morbidity in order to move the insurance industry forward. In response to the pandemic, the LLF awarded a special interim grant to investigate potential predictive biomarkers of more serious COVID-19 disease. The research aims to allow doctors to identify which patients might be at the highest risk of experiencing severe outcomes and potentially help improve morbidity and mortality outcomes.

The role of medical directors at life and health insurers and reinsurers was already rapidly evolving to keep pace with medical advances and industry developments, and it was further accelerated by the pandemic. RGA’s medical team rose to the many challenges of 2020, equipping clients with a deeper understanding of the latest mortality, morbidity, and healthcare developments and trends and helping deliver consumer-focused insurance solutions across all regions.

    • Doug Knowling
      Doug Knowling

      Chief Data and Analytics Officer, Global Data and Analytics

    Building trust through ethical data practices

    “RGA is built on data, and responsible use of that data requires the constant assessment of practices across our global operations.”

    READ MORE

Risk Solutions

Article Hub

  • RGARE.COM

Copyright © 2021 Reinsurance Group of America, Incorporated. All rights reserved.

Webmaster | Legal Notice and Terms of Use | Web Privacy | Privacy Notice | Rights Requests